濮阳东方医院男科治阳痿收费便宜濮阳东方医院看早泄咨询电话,濮阳市东方医院非常好,濮阳市东方医院评价如何,濮阳东方医院妇科在什么位置,濮阳东方妇科医院做人流贵吗,濮阳东方医院看男科病收费低,濮阳东方看男科技术非常专业

BEIJING, Dec. 20 (Xinhua) -- A senior Chinese official called for a higher level of requirements for promoting cultural and ethical progress at a national conference Tuesday.Li Changchun, a member of the Standing Committee of the Political Bureau of the Communist Party of China (CPC) Central Committee urged for efforts to "provide firm ideological assurance, powerful spiritual drive, effective media support and sound cultural conditions for achieving the great goal of building an overall prosperous society."Li, also director of the Central Spiritual Civilization Development Steering Commission, made the remark while addressing the National Award-issuing Conference on the Work of Cultural and Ethical Progress.Li Changchun (1st L), a Standing Committee member of the Political Bureau of the Communist Party of China (CPC) Central Committee and director of the Central Spiritual Civilization Development Steering Commission, presents the awards to the advanced collectives and individuals during the National Award-issuing Conference on the Work of Cultural and Ethical Progress held in Beijing, capital of China, Dec. 20, 2011. Li attended the conference on Tuesday and gave a speech.In his speech, Li extended his gratefulness to everyone engaged in cultural and ethical work at all levels, as well as to people from all walks of life for their active participation in, and support of, the work.Currently, publicizing the Party's new plenary session should be the primary task in cultural and ethical work, Li said."Cultural and ethical progress is a major component of the socialist cause with China's own characteristics," he said, emphasizing that substantial efforts must be made to strengthen Party leadership on the work.The meeting was presided over by Liu Yunshan, a member of the Political Bureau of the CPC Central Committee and deputy-director of the Central Spiritual Civilization Development Steering Commission.In an address at the gathering, he called for greater efforts in publicizing the models of cultural and ethical progress, so as to "enhance the level of civilization of the society as a whole."A total of 27 cities and municipal districts, 899 villages and small towns, and 1,794 institutions and enterprises were awarded for their marked achievements in cultural and ethical progress, and 23 cities and municipal districts that had been previously awarded were allowed to keep their honorary titles.

JERUSALEM, Jan. 12 (Xinhua) -- An Israeli company has developed a system that scans the brain and provides a three dimensional image of the nerve cell connectivity to treat brain diseases like Alzheimer's or HDHD.The firm ElMindA trademarked a non-invasive system, the BNA ( Brain Network Activation), that helps doctors visualize the connectivity between nerve cells and synchronization that can even measure the severity of the patients condition from one day to another, the Israel21c news site reported on ThursdayBy creating a three-dimensional image of the brain while asking the patients to repeat an activity several times, BNA developers hope this system will become a regular way of diagnosing brain illnesses."Our vision is that every psychiatrist and neurologist in the world will routinely send every patient for BNA tests," said Dr. Eli Zangvil, ElMindA's strategic advisor for business development. "Our test would add information and aid in diagnostics in a way no other existing technology can do," he added.BNA could help doctors find out exactly at what stage of the disease patients and prescribe the exact medication for them."To do that, we must collect a lot of data," Zangvil said. "To say this person has a certain disease or condition, I have to be able to compare their pattern to a normal brain pattern of a person of the same age and gender." he said.Researchers hope to gather the amount of data they need to obtain FDA approval in the U.S. by the end of 2012, and start marketing it to hospitals by 2013.

WASHINGTON, Nov. 7 (Xinhua) -- U.S. researchers have demonstrated for the first time that the brain is a key player in regulating glucose (sugar) metabolism in humans.The findings, published Monday in the online edition of the Journal of Clinical Investigation, suggest that drugs targeting the brain and central nervous system could be a novel approach to treating diabetes."The brain is the body's only organ that needs a constant supply of glucose to survive, so it makes sense that it would have some say over how much glucose is produced," said study leader Meredith Hawkins, professor of medicine and director of the Global Diabetes Initiative at Yeshiva University, in a statement. "This role for the brain was demonstrated in earlier studies in rodents, but there was considerable controversy over whether the results could be applied to humans. We hope this study helps to settle the matter."In an earlier study in rodents, researchers showed that activation of potassium channels in the brain's hypothalamus sends signals to the liver that dampen its production of glucose. Those findings, published in Nature in 2005, challenged the conventional thinking that blood sugar production by the liver (the body's glucose factory) is regulated only by the pancreas (which makes insulin to metabolize glucose). But carefully performed studies on dogs, conducted at Vanderbilt University, failed to replicate the results, suggesting the Einstein findings in rodents might not be relevant to higher mammals, including humans.The current study, involving people, was aimed at resolving this controversy. Ten nondiabetic subjects were given oral diazoxide, a drug that activates potassium channels in the hypothalamus. (The drug is not used to treat diabetes.) Hormone secretion by the pancreas was controlled to ensure that any change in sugar production would only have occurred through the drug's effect on the brain. After the researchers administered the drug, blood tests revealed that patients' livers were producing significantly less glucose than before.Hawkins and her team then repeated this in rats, again giving diazoxide orally, achieving similar results. They confirmed that sufficient amounts of diazoxide crossed the blood-brain barrier to affect potassium channels in the hypothalamus. Additional experiments confirmed that diazoxide was working through the brain. Specifically, the researchers were able to completely block the effects of diazoxide by infusing a specific potassium channel blocker directly into the brain."This study confirms that the brain plays a significant role in regulating glucose production by the liver," said lead author Preeti Kishore, assistant professor of medicine. "We are now investigating whether this 'brain-to-liver' pathway is impaired in people with diabetes. If so, we may be able to restore normal glucose regulation by targeting potassium channels in the brain."

SAN FRANCISCO, Nov. 21 (Xinhua) -- Hewlett-Packard Co. (HP) on Monday reported that its profit in the most recent quarter fell more than 90 percent with sales also declining.In the company's fourth quarter of fiscal 2011 ended Oct. 31, the company posted net earnings of 239 million U.S. dollars, compared with 2.54 billion dollars in the same period a year earlier.HP's net revenue for the quarter reached 32.1 billion dollars, down 3 percent year-on-year.Excluding one-time items, HP earned 1.17 dollars per share, which topped estimates of analysts.According to Thomson Reuters, analysts had expected earnings of 1.13 dollars per share on revenue of 32.05 billion dollars.It was the first earnings report since Meg Whitman took over as chief executive officer (CEO) of the information technology giant on Sept. 22, replacing Leo Apotheker."HP has a great opportunity to build on our strong hardware, software, and services franchises with leading market positions, customer relationships, and intellectual property," Whitman said in a statement after the earnings announcement."We need to get back to the business fundamentals in fiscal 2012, including making prudent investments in the business and driving more consistent execution," she added.